Cover Image
市場調查報告書

精神病:全球臨床實驗檢討

Psychosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 167093
出版日期 內容資訊 英文 92 Pages
訂單完成後即時交付
價格
Back to Top
精神病:全球臨床實驗檢討 Psychosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月28日 內容資訊: 英文 92 Pages
簡介

本報告提供精神病相關臨床研究之最新趨勢相關分析,為您彙整疾病·治療方法概要,及G7各國與E7(新興7國)的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,再加上各企業及研究機關的研究進行狀況,及有潛力的藥劑比較等資訊。

簡介

  • 精神病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 精神病臨床實驗數量中,中樞神經系統臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 精神病臨床實驗數量中,中樞神經系統臨床實驗數量所佔的比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 精神病治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Johnson & Johnson
    • AstraZeneca PLC
    • Eli Lilly and Company
    • Pfizer Inc.
    • 大塚集團
    • ZonMw
    • North Shore-Long Island Jewish Health System, Inc.
    • Acadia Pharmaceuticals Inc.
  • 有代表性的研究機關醫院臨床實驗概要
    • Department of Health, South Africa
    • Yale University
    • U.S. Department of Veterans Affairs
    • The University of Hong Kong
    • Maastricht University
    • Centre for Addiction and Mental Health
    • University of British Columbia
    • Melbourne Health
    • University of Cologne
    • New York State Psychiatric Institute

5大臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2266CTIDB

GlobalData's clinical trial report, "Psychosis Global Clinical Trials Review, H2, 2014" provides data on the Psychosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psychosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Psychosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Psychosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Psychosis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Psychosis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Psychosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Psychosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • ZonMw
      • Clinical Trial Overview of ZonMw
      • North Shore-Long Island Jewish Health System, Inc.
      • Clinical Trial Overview of North Shore-Long Island Jewish Health System, Inc.
      • Acadia Pharmaceuticals Inc.
      • Clinical Trial Overview of Acadia Pharmaceuticals Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • Yale University
      • Clinical Trial Overview of Yale University
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • Maastricht University
      • Clinical Trial Overview of Maastricht University
      • Centre for Addiction and Mental Health
      • Clinical Trial Overview of Centre for Addiction and Mental Health
      • University of British Columbia
      • Clinical Trial Overview of University of British Columbia
      • Melbourne Health
      • Clinical Trial Overview of Melbourne Health
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
      • New York State Psychiatric Institute
      • Clinical Trial Overview of New York State Psychiatric Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Psychosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Psychosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Psychosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Psychosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Psychosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Psychosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Psychosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Psychosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Psychosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Psychosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Psychosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Psychosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore-Long Island Jewish Health System, Inc., 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Acadia Pharmaceuticals Inc., 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Melbourne Health, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014*
  • Psychosis Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014*

List of Figures

  • Psychosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Psychosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Psychosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Psychosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Psychosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Psychosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Proportion of Psychosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Psychosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Psychosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Psychosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Psychosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Psychosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Psychosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Psychosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Psychosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Psychosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top